Psoriatic arthritis treated with oral zinc sulphate. 1980

O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch

Twenty-four patients suffering from psoriatic arthritis participated in a double blind cross-over trial of peroral zinc sulphate versus placebo (Trial I). Eleven patients continued an open trial of peroral zinc sulphate for an additional 24 weeks (Trial II). Remission was assessed by the disappearance of symptoms (overall condition, morning stiffness, functional capacity of the joints and joint pains), and signs (mobility and swelling of the joints). Reduction of joint pains as well as increase of mobility and decrease of swelling of several joints were observed. the clinical signs of reduced inflammation were accompanied biochemically by reduction of serum immunoglobulins and an increase of serum albumin. The need for analgesics was diminished. Severe side-effects and changes in the psoriatic skin involvement were not seen. Oral zinc sulphate seems to be valuable in the treatment of psoriatic arthritis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
August 1987, The Journal of rheumatology,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
October 1976, Danish medical bulletin,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
September 1976, Lancet (London, England),
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
January 2006, Annals of Saudi medicine,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
January 1984, Scandinavian journal of rheumatology,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
January 1980, The Journal of rheumatology,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
June 1982, The British journal of dermatology,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
January 1977, Progress in clinical and biological research,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
October 1982, Annals of the rheumatic diseases,
O J Clemmensen, and J Siggaard-Andersen, and A M Worm, and D Stahl, and F Frost, and I Bloch
December 1992, Allergie et immunologie,
Copied contents to your clipboard!